{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:54:47Z","timestamp":1757454887677},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T00:00:00Z","timestamp":1358899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00467-012-2406-3","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T04:27:50Z","timestamp":1358828870000},"page":"911-918","source":"Crossref","is-referenced-by-count":41,"title":["Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome"],"prefix":"10.1007","volume":"28","author":[{"given":"St\u00e9phanie","family":"Tellier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Bandin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Llanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Guigonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Cailliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Pietrement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Dunand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lia","family":"Bertholet-Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Ichay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Decramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"2406_CR1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00467-009-1226-6","volume":"24","author":"D Haffner","year":"2009","unstructured":"Haffner D, Fischer DC (2009) Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol 24:1433\u20131438","journal-title":"Pediatr Nephrol"},{"key":"2406_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MOP.0b013e3282f4307a","volume":"20","author":"EM Hodson","year":"2008","unstructured":"Hodson EM, Alexander SI (2008) Evaluation and management of steroid-sensitive nephrotic syndrome. Curr Opin Pediatr 20:145\u2013150","journal-title":"Curr Opin Pediatr"},{"key":"2406_CR3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269\u20131279","journal-title":"Pediatr Nephrol"},{"key":"2406_CR4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00467-010-1465-6","volume":"25","author":"AL Sellier-Leclerc","year":"2010","unstructured":"Sellier-Leclerc AL, Macher MA, Loirat C, Guerin V, Watier H, Peuchmaur M, Baudouin V, Deschenes G (2010) Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 25:1109\u20131115","journal-title":"Pediatr Nephrol"},{"key":"2406_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199401063300102","volume":"330","author":"J Dantal","year":"1994","unstructured":"Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. New Eng J Med 330:7\u201314","journal-title":"New Eng J Med"},{"key":"2406_CR6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","volume":"10","author":"HK Yap","year":"1999","unstructured":"Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529\u2013537","journal-title":"J Am Soc Nephrol"},{"key":"2406_CR7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00467-008-1092-7","volume":"24","author":"A Iharada","year":"2009","unstructured":"Iharada A, Kaneko K, Tsuji S, Hasui M, Kanda S, Nishiyama T (2009) Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome. Pediatr Nephrol 24:1033\u20131038","journal-title":"Pediatr Nephrol"},{"key":"2406_CR8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF00853431","volume":"2","author":"R Habib","year":"1988","unstructured":"Habib R, Girardin E, Gagnadoux MF, Hinglais N, Levy M, Broyer M (1988) Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular \"immune deposits\". Pediatr Nephrol 2:402\u2013408","journal-title":"Pediatr Nephrol"},{"key":"2406_CR9","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1681\/ASN.V991709","volume":"9","author":"J Dantal","year":"1998","unstructured":"Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, Bouhours JF, Soulillou JP (1998) Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9:1709\u20131715","journal-title":"J Am Soc Nephrol"},{"key":"2406_CR10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cyto.990140212","volume":"14","author":"LE Hultin","year":"1993","unstructured":"Hultin LE, Hausner MA, Hultin PM, Giorgi JV (1993) CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry 14:196\u2013204","journal-title":"Cytometry"},{"key":"2406_CR11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","volume":"19","author":"K Benz","year":"2004","unstructured":"Benz K, Dotsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794\u2013797","journal-title":"Pediatr Nephrol"},{"key":"2406_CR12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00467-006-0427-5","volume":"22","author":"GC Smith","year":"2007","unstructured":"Smith GC (2007) Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol 22:893\u2013898","journal-title":"Pediatr Nephrol"},{"key":"2406_CR13","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","volume":"21","author":"RD Gilbert","year":"2006","unstructured":"Gilbert RD, Hulse E, Rigden S (2006) Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol 21:1698\u20131700","journal-title":"Pediatr Nephrol"},{"key":"2406_CR14","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/ndt\/gfm128","volume":"22","author":"JM Hofstra","year":"2007","unstructured":"Hofstra JM, Deegens JK, Wetzels JF (2007) Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome? Nephrol Dial Transpl 22:2100\u20132102","journal-title":"Nephrol Dial Transpl"},{"key":"2406_CR15","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. New Eng J Med 356:2751\u20132752","journal-title":"New Eng J Med"},{"key":"2406_CR16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","volume":"23","author":"M Nakayama","year":"2008","unstructured":"Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K (2008) Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 23:481\u2013485","journal-title":"Pediatr Nephrol"},{"key":"2406_CR17","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207\u20132212","journal-title":"Clin J Am Soc Nephrol"},{"key":"2406_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00467-009-1376-6","volume":"25","author":"A Prytula","year":"2010","unstructured":"Prytula A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A, Taylor M, Marks SD, Tuchman S, Camilla R, Ognjanovic M, Filler G, Smith G, Tullus K (2010) Rituximab in refractory nephrotic syndrome. Pediatr Nephrol 25:461\u2013468","journal-title":"Pediatr Nephrol"},{"key":"2406_CR19","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc055495","volume":"354","author":"MD Pescovitz","year":"2006","unstructured":"Pescovitz MD, Book BK, Sidner RA (2006) Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. New Eng J Med 354:1961\u20131963","journal-title":"New Eng J Med"},{"key":"2406_CR20","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s00467-005-2013-7","volume":"20","author":"K Nozu","year":"2005","unstructured":"Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M (2005) Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 20:1660\u20131663","journal-title":"Pediatr Nephrol"},{"key":"2406_CR21","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","volume":"27","author":"MJ Kemper","year":"2011","unstructured":"Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dotsch J (2011) Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant 27:1910\u20131915","journal-title":"Nephrol Dial Transplant"},{"key":"2406_CR22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"AL Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guerin V, Lapillonne H, Deschenes G, Ulinski T (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2013follow-up after CD19 recovery. Nephrol Dial Transplant 27:1083\u20131089","journal-title":"Nephrol Dial Transplant"},{"key":"2406_CR23","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00467-011-1886-x","volume":"26","author":"S Ito","year":"2011","unstructured":"Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K (2011) Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:1823\u20131828","journal-title":"Pediatr Nephrol"},{"key":"2406_CR24","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00467-011-1894-x","volume":"26","author":"G Filler","year":"2011","unstructured":"Filler G, Huang SH, Sharma AP (2011) Should we consider MMF therapy after rituximab for nephrotic syndrome? Pediatr Nephrol 26:1759\u20131762","journal-title":"Pediatr Nephrol"},{"key":"2406_CR25","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1523-1755.2005.00322.x","volume":"67","author":"H Mansour","year":"2005","unstructured":"Mansour H, Cheval L, Elalouf JM, Aude JC, Alyanakian MA, Mougenot B, Doucet A, Deschenes G (2005) T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome. Kidney Int 67:2168\u20132177","journal-title":"Kidney Int"},{"key":"2406_CR26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.172.1.688","volume":"172","author":"A Valanciute","year":"2004","unstructured":"Valanciute A, le Gouvello S, Solhonne B, Pawlak A, Grimbert P, Lyonnet L, Hue S, Lang P, Remy P, Salomon R, Bensman A, Guellaen G, Sahali D (2004) NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome. J Immunol 172:688\u2013698","journal-title":"J Immunol"},{"key":"2406_CR27","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1681\/ASN.V1281648","volume":"12","author":"D Sahali","year":"2001","unstructured":"Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciute A, Remy P, Loirat C, Niaudet P, Bensman A, Guellaen G (2001) Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol 12:1648\u20131658","journal-title":"J Am Soc Nephrol"},{"key":"2406_CR28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bcp.2006.08.007","volume":"72","author":"E Dejardin","year":"2006","unstructured":"Dejardin E (2006) The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol 72:1161\u20131179","journal-title":"Biochem Pharmacol"},{"key":"2406_CR29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(00)00067-4","volume":"13","author":"RE Voll","year":"2000","unstructured":"Voll RE, Jimi E, Phillips RJ, Barber DF, Rincon M, Hayday AC, Flavell RA, Ghosh S (2000) NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity 13:677\u2013689","journal-title":"Immunity"},{"key":"2406_CR30","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/ndt\/gfs035","volume":"27","author":"R Coppo","year":"2012","unstructured":"Coppo R, Camilla R, Porcellini MG, Peruzzi L, Gianoglio B, Amore A, Dapra V, Loiacono E, Fonsato V, Dal Canton A, Esposito C, Esposito P, Tovo PA (2012) Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study. Nephrol Dial Transplant 27:1902\u20131910","journal-title":"Nephrol Dial Transplant"},{"key":"2406_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrneurol.2011.1","volume":"7","author":"X Bosch","year":"2011","unstructured":"Bosch X, Saiz A, Ramos-Casals M (2011) Monoclonal antibody therapy-associated neurological disorders. Nat Rev Neurol 7:165\u2013172","journal-title":"Nat Rev Neurol"},{"key":"2406_CR32","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1053\/gast.2000.19269","volume":"119","author":"L Ricciardiello","year":"2000","unstructured":"Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE, Boland CR (2000) JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 119:1228\u20131235","journal-title":"Gastroenterology"},{"key":"2406_CR33","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1128\/JVI.00441-06","volume":"80","author":"LA Shackelton","year":"2006","unstructured":"Shackelton LA, Rambaut A, Pybus OG, Holmes EC (2006) JC virus evolution and its association with human populations. J Virol 80:9928\u20139933","journal-title":"J Virol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2406-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-012-2406-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2406-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T12:26:30Z","timestamp":1644150390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-012-2406-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2406"],"URL":"https:\/\/doi.org\/10.1007\/s00467-012-2406-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}